Pedro Barata

Associate Professor of Medicine

University Hospitals Seidman Cancer Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pedro Barata is an Associate Professor of Medicine at the University Hospitals Seidman Cancer Center. He focuses his research on prostate cancer, with recent articles addressing quality-of-life challenges for patients with advanced stages of the disease, as well as the implementation of genetic testing into standard care. His work also includes evaluating treatment strategies and outcomes for various types of cancer, such as renal cell carcinoma and urothelial carcinoma, reflecting a comprehensive approach to oncology.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Channing Paller

Johns Hopkins University

UNITED STATES

View details

Justin Hwang

Assistant Professor

University of Minnesota

UNITED STATES

View details

Silke Gillessen

The University of Manchester

UNITED KINGDOM

View details

Jason Brown

Assistant Professor

University Hospital

UNITED STATES

View details

Alan Haruo Bryce

Chief Clinical Officer

City of Hope

UNITED STATES

View details

Robert Dess

University of Michigan

UNITED STATES

View details

Emmanuel Stylianos Antonarakis

Professor of Medicine, Associate Director for Translation

UNITED STATES

View details

Carly Miller

University of Minnesota

UNITED STATES

View details

Kevin Kelly

Thomas Jefferson University

UNITED STATES

View details

Catherine Tangen

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pedro Barata

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

The Influence of the Germline <i>HSD3B1</i> Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer

Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now

Addressing quality-of-life challenges for patients with end-stage metastatic castrate-resistant prostate cancer

Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men

STELLAR-304: a phase III study of zanzalintinib (XL092) plus nivolumab in advanced non-clear cell renal cell carcinoma

High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial

Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma

Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study

Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond

Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study

Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study

Symptom Clusters in Patients With Advanced Cancer: A Prospective Longitudinal Cohort Study to Examine Their Stability and Prognostic Significance

Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis

Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy

Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial

Association of Androgen Deprivation Therapy with Metabolic Disease in Prostate Cancer Patients: An Updated Meta-Analysis

Clinical and Genetic Analysis of Metastatic Prostate Cancer to the Central Nervous System: A Single-Institution Retrospective Experience

Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab

Collaborators (10)

Channing Paller

Justin Hwang

Silke Gillessen

Jason Brown

Alan Haruo Bryce

Robert Dess

Emmanuel Stylianos Antonarakis

Carly Miller

Kevin Kelly

Catherine Tangen

Make your next move.